Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival

Title
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
Authors
Keywords
Trial design, Liver cancer, Systemic therapies, FDA approval
Journal
JOURNAL OF HEPATOLOGY
Volume 70, Issue 6, Pages 1262-1277
Publisher
Elsevier BV
Online
2019-04-01
DOI
10.1016/j.jhep.2019.01.028

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started